2021
DOI: 10.1016/j.tmaid.2020.101923
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 disease severity and mortality determinants: A large population-based analysis in Oman

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
6
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 3 publications
6
6
1
Order By: Relevance
“…However, spleens can persist in SCA patients to adult life where the thalassaemia gene is carried in association with the sickle gene mutation, and the COVID group had a high prevalence of both the alpha and beta thalassemia genes (Alkindi et al, 2010). Fever, cough, fatigue, abdominal pain and anosmia were the lead presenting symptoms in the COVID group (P < 0.5, Chi-Square test), similar to the general population and as reported among sickle cell disease cohorts (Al Wahaibi et al, 2020;Balanchivadze et al, 2020;Khamis et al, 2020). In their report from the same population, Khamis et al (2020) reported that 95.9% of cases were mild, 3.6% moderate and 0.5% severe, with a case fatality rate of 0.5% in the non-SCA population.…”
Section: Discussionsupporting
confidence: 74%
See 1 more Smart Citation
“…However, spleens can persist in SCA patients to adult life where the thalassaemia gene is carried in association with the sickle gene mutation, and the COVID group had a high prevalence of both the alpha and beta thalassemia genes (Alkindi et al, 2010). Fever, cough, fatigue, abdominal pain and anosmia were the lead presenting symptoms in the COVID group (P < 0.5, Chi-Square test), similar to the general population and as reported among sickle cell disease cohorts (Al Wahaibi et al, 2020;Balanchivadze et al, 2020;Khamis et al, 2020). In their report from the same population, Khamis et al (2020) reported that 95.9% of cases were mild, 3.6% moderate and 0.5% severe, with a case fatality rate of 0.5% in the non-SCA population.…”
Section: Discussionsupporting
confidence: 74%
“…The other patient died with COVID-related pneumonia, renal failure and occipital infarction. Both patients had a history of asthma, ACS (2 factors also seen in COVID-19 in the general population) and splenectomy (Al Wahaibi et al, 2020). The COVID group mortality rate is consistent with a French study where COVID-19 mortality among SCA patients was not severe (Arlet et al, 2020); this is thought to be partly due to SCA patients being young and selfisolated, and there may also be a protective effect against COVID-19 driven by cytokine profile (Arlet et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Although most patients are considered mild cases, severe COVID-19 infection can lead to complications and higher mortality [ 70 ]. In our meta-analysis, severe cases had an approximately 3-fold higher risk of developing ocular symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…Development in any field can only be achieved by activating the field of scientific research through which decisions are made and reviewed on solid scientific grounds. Examples of research conducted in Oman during the COVID-19 pandemic that aided decision making include a national sero-prevalence survey conducted for COVID-19 disease in the community ( 20 ), a multicenter serological study for health care worker exposure risks and infection ( 21 ), and a large population-based analysis of severity and mortality determinants ( 22 ). Additionally, a pre-campaign cross-sectional knowledge, attitudes, and practices (KAP) study of the COVID-19 vaccine was done ( 23 ).…”
Section: During the Covid-19 Pandemic: Challenges Opportunities And Resiliencementioning
confidence: 99%